Diagnosis and management of treatment-related osteoporosis in men with prostate carcinoma
- 23 January 2003
- Vol. 97 (S3) , 789-795
- https://doi.org/10.1002/cncr.11149
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Intravenous Zoledronic Acid in Postmenopausal Women with Low Bone Mineral DensityNew England Journal of Medicine, 2002
- Alendronate for the Treatment of Osteoporosis in MenNew England Journal of Medicine, 2000
- BONE MINERAL DENSITY IN MEN TREATED WITH SYNTHETIC GONADOTROPIN-RELEASING HORMONE AGONISTS FOR PROSTATIC CARCINOMAJournal of Urology, 1999
- Comparative Tolerability of Drug Therapies for Hypercalcaemia of MalignancyDrug Safety, 1999
- Osteoporosis After Orchiectomy for Prostate CancerJournal of Urology, 1997
- Estrogens in the Treatment of Prostate CancerJournal of Urology, 1995
- Endocrine profiles during administration of the new non‐steroidal anti‐androgen Casodex in prostate cancerClinical Endocrinology, 1994
- Bone density at various sites for prediction of hip fracturesThe Lancet, 1993
- Leuprolide versus Diethylstilbestrol for Metastatic Prostate CancerNew England Journal of Medicine, 1984